moxalactam has been researched along with imipenem, anhydrous in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (62.71) | 18.7374 |
1990's | 6 (10.17) | 18.2507 |
2000's | 11 (18.64) | 29.6817 |
2010's | 5 (8.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Girlich, D; Nordmann, P; Poirel, L | 3 |
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
Blaser, J | 1 |
Crine, M; Frère, JM; Joris, B; Martin, HH | 1 |
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Avril, JL; Donnio, PY; Lebert, P; Travert, MF | 1 |
Blaser, J; Zinner, SH | 1 |
Agueda, L; Chabanon, G; Dournes, JL; Lapchine, L; Marty, N | 1 |
Marks, MI; Parker, KM; Stutman, HR | 1 |
Amicosante, G; Frère, JM; Galleni, M | 1 |
Bustamante, CI; Drusano, GL; Forrest, A; Leslie, J; Moody, M; Rivera, G; Standiford, HC; Tatem, B | 1 |
Defresne, N; Husson, M; Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
Bourgault, AM; Horn, R; Lamothe, F | 1 |
Eley, A; Greenwood, D | 1 |
Hashizume, T; Sawai, T; Yamaguchi, A | 1 |
Berkeley, AS; Freedman, KS; Hirsch, JC; Ledger, WJ | 1 |
Jones, RN | 1 |
Andrew, JH; Dixson, S | 1 |
Cohn, DL; Reimer, LG; Reller, LB | 1 |
Freimer, EH; Gilardi, GL; O'Donnell, ED; Raeder, R | 1 |
Cynamon, MH; Granato, PA | 1 |
Brown, JE; Collins, CD; Del Bene, VE | 1 |
Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Verbist, L; Verhaegen, J | 1 |
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Fekety, FR; McClatchey, KD; Pierson, CL; Schaberg, DR | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Neu, HC | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF | 1 |
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Meyer, RD; Pasiecznik, K | 1 |
Cullmann, W; Dick, W | 1 |
Calandra, GB; Grad, C; Hesney, M | 1 |
Bustamante, CI; Drusano, GL; Standiford, HC; Tatem, BA | 1 |
Eron, LJ; Goldenberg, RI; Hixon, DL; Park, CH; Poretz, DM | 1 |
Brunschwig, C; Jourdan, J; O'Callaghan, D; Ramuz, M; Sotto, A | 1 |
Borowiecka, B; Chojnowski, W; Pajchel, G | 1 |
Buu-Hoï, A; Collatz, E; Coutrot, A; Gutmann, L; Mainardi, JL; Mugnier, P | 1 |
Beadle, BM; Nicholas, RA; Shoichet, BK | 1 |
Beadle, BM; Shoichet, BK; Trehan, I | 1 |
Minasov, G; Shoichet, BK; Wang, X | 1 |
Ji, JS; Quan, JJ; Wang, HP; Wang, Y; Wang, YF; Xu, YC; Yu, YS | 1 |
Benvenuti, M; De Luca, F; Docquier, JD; Mangani, S; Nordmann, P; Poirel, L; Pozzi, C; Rossolini, GM | 1 |
2 review(s) available for moxalactam and imipenem, anhydrous
Article | Year |
---|---|
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
7 trial(s) available for moxalactam and imipenem, anhydrous
Article | Year |
---|---|
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
Topics: Adolescent; Adult; Bacteria; Cilastatin; Cyclopropanes; Humans; Imipenem; Injections, Intravenous; Kinetics; Male; Moxalactam; Protein Binding; Thienamycins | 1986 |
Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole.
Topics: Adult; Bacteria, Anaerobic; Clindamycin; Female; Humans; Imipenem; Male; Metronidazole; Moxalactam; Random Allocation; Thienamycins | 1987 |
Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
Topics: Acute Disease; Adolescent; Adult; Cesarean Section; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Dipeptidases; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Humans; Imipenem; Moxalactam; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Thienamycins | 1986 |
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Tolerance; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1984 |
Imipenem versus moxalactam in the treatment of serious infections.
Topics: Adult; Aged; Bacterial Infections; Female; Humans; Imipenem; Inflammation; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1983 |
50 other study(ies) available for moxalactam and imipenem, anhydrous
Article | Year |
---|---|
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--II. Non-steady-state treatment and progress curves.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Ceftazidime; Gram-Negative Bacteria; Hexosyltransferases; Imipenem; Mathematics; Microbial Sensitivity Tests; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1989 |
[Action of imipenem on Enterobacter cloacae].
Topics: Cefotaxime; Cefoxitin; Ceftazidime; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Imipenem; Moxalactam; Penicillin Resistance; Phenotype; Piperacillin; Thienamycins | 1988 |
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins | 1986 |
Effects of five antibiotics on adhesion and haemagglutinating properties of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Cefsulodin; Ceftazidime; Cystic Fibrosis; Guinea Pigs; Hemagglutination; Humans; Imipenem; Microscopy, Electron; Moxalactam; Pefloxacin; Pseudomonas aeruginosa; Sputum | 1988 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
Topics: Aztreonam; beta-Lactamases; Cephalosporins; Hydrolysis; Imipenem; Kinetics; Moxalactam; Substrate Specificity | 1988 |
Disk diffusion susceptibility testing of the Bacteroides fragilis group.
Topics: Bacteroides fragilis; Cefoxitin; Chloramphenicol; Clindamycin; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins; Ticarcillin | 1987 |
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Thienamycins | 1986 |
Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cell Membrane Permeability; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1986 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalothin; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Sepsis; Tobramycin | 1982 |
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1981 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1981 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephamycins; Humans; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1981 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Investigations on beta-lactamase stability of recently developed beta-lactam compounds: study of enzyme kinetics.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Citrobacter; Enterobacter; Enterobacteriaceae; Escherichia coli; Imipenem; Moxalactam; Thienamycins | 1983 |
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Imipenem; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1984 |
In-vitro evaluation of beta-lactamase inhibition by latamoxef and imipenem.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Imipenem; In Vitro Techniques; Moxalactam; Thienamycins | 1996 |
[Determination of moxalactam, aztreonam and imipenem by the perchloric hydroxylamine method].
Topics: Anti-Bacterial Agents; Aztreonam; Drug Stability; Hydroxylamine; Hydroxylamines; Imipenem; Moxalactam | 1992 |
Carbapenem resistance in a clinical isolate of Citrobacter freundii.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Citrobacter freundii; Drug Resistance, Microbial; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxalactam; Plasmids; Thienamycins | 1997 |
Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cefoxitin; Circular Dichroism; Cloxacillin; Escherichia coli; Hexosyltransferases; Imipenem; Models, Chemical; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Protein Denaturation; Spectrometry, Fluorescence; Temperature; Thermodynamics | 2001 |
Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
Topics: Alanine; Amino Acid Substitution; Asparagine; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Crystallization; Crystallography, X-Ray; Enzyme Stability; Escherichia coli; Imipenem; Kinetics; Moxalactam; Mutagenesis, Site-Directed; Protein Denaturation; Thermodynamics | 2001 |
Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Energy Metabolism; Enzyme Inhibitors; Enzyme Stability; Imipenem; Macromolecular Substances; Models, Chemical; Models, Molecular; Moxalactam; Protein Conformation; Protein Denaturation; Temperature | 2002 |
[The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus; Thienamycins | 2016 |
Crystal Structure of the Pseudomonas aeruginosa BEL-1 Extended-Spectrum β-Lactamase and Its Complexes with Moxalactam and Imipenem.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Citric Acid; Crystallography, X-Ray; Disulfides; Imipenem; Moxalactam | 2016 |